Trials / Terminated
TerminatedNCT02159183
Controlled Pilot Study to Assess Soft Tissue Reaction at the Crestal Part of a Dental Implant With ESTA Surface
A Controlled Clinical Pilot Study to Assess Soft Tissue Reaction at the Crestal Part of a Dental Implant With ESTA Surface
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Institut Straumann AG · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the effect on the soft tissue that is in contact with a dental implant with a modified surface of the neck (the part of the implant that is above the bone and in contact with the soft gum tissue).
Detailed description
This is a prospective, controlled, randomised clinical pilot study with parallel groups and blinded subject. The design has been chosen to obtain data to base a sample size calculation for future studies on by comparing the degree of mucosal inflammation of the mucosa in conjunction with the modified surface of the top of the test implant and the machined surface on the top of the control implant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Standard Plus ESTA STL Roxolid implant | The patient will receive a Straumann Soft Tissue Level Standard Plus Implant Ø 4.1 mm Regular Neck, SLActive® Roxolid, with a modified surface of the neck (ESTA). At 8-12 weeks after insertion, the implant will be loaded. |
| DEVICE | Standard Plus STL implant | The patient will receive a Straumann Soft Tissue Level Standard Plus Implant Ø4.1mm Regular Neck,SLActive® Titanium grade IV, with a machined surface of the neck. At 8-12 weeks after insertion, the implant will be loaded. |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-09-01
- Completion
- 2016-09-27
- First posted
- 2014-06-09
- Last updated
- 2019-04-02
- Results posted
- 2019-03-07
Locations
4 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02159183. Inclusion in this directory is not an endorsement.